Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

P-MUC1C-ALLO1

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Poseida Therap

Drug class:

MUC1-targeted CAR-T immunotherapy

Related drugs:

‹

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)

Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)

Tn MUC1 CAR T-cell therapy (0)

anti-MUC1 CAR-T cells (0)

anti-MUC1 CAR-T cells (0)

huMNC2-CAR22 (0)

huMNC2-CAR44 CAR T cells (0)

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)

Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)

Tn MUC1 CAR T-cell therapy (0)

anti-MUC1 CAR-T cells (0)

anti-MUC1 CAR-T cells (0)

huMNC2-CAR22 (0)

huMNC2-CAR44 CAR T cells (0)

›

MUC1 expression	Ovarian Cancer	MUC1 expression	Ovarian Cancer	P-MUC1C-ALLO1 Sensitive: D – Preclinical P-MUC1C-ALLO1 Sensitive : D	P-MUC1C-ALLO1 Sensitive: D – Preclinical P-MUC1C-ALLO1 Sensitive : D
MUC1 expression	Breast Cancer	MUC1 expression	Breast Cancer	P-MUC1C-ALLO1 Sensitive: D – Preclinical P-MUC1C-ALLO1 Sensitive : D	P-MUC1C-ALLO1 Sensitive: D – Preclinical P-MUC1C-ALLO1 Sensitive : D